Ahead of its mega-IPO, SpaceX revealed healthcare ambitions in its SEC filing, highlighting Starlink's role in improving remote healthcare access in underserved areas. The company also envisions manufacturing pharmaceuticals in orbit, leveraging microgravity to enhance drug properties, a concept tested by other pharma firms. Additionally, SpaceX sees AI as a key tool for accelerating scientific discovery and medical diagnosis, though its AI chatbot Grok has faced challenges in providing accurate health advice. These moves signal SpaceX's potential to expand beyond aerospace into healthcare innovation.
Meta is developing a cloud infrastructure business to sell access to its AI compute power and models, entering competition with major cloud providers like Amazon Web Services, Google Cloud, and Microsoft Azure. This move follows similar plans by Spac...
Rocket Lab is acquiring Iridium Communications in an $8 billion cash-and-stock deal to combine its rocket launch and satellite manufacturing business with Iridium’s global low-Earth-orbit satellite network and valuable wireless spectrum rights. This ...
